Photo: STAT
Health
STAT+: Zolgensma tumor cases show risks of a common gene therapy tool
TL;DR
- New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 6, 2026 · Updated 11/6/2026, 4:30:44 PM · Reported with: STAT
Sources (1)
NRI Bytes writes its own articles from the reporting below.
STAT — STAT+: Zolgensma tumor cases show risks of a common gene therapy toolUp next · Health
Sen. Chris Murphy out of hospital, will miss votes after stroke
Read next →
More stories
Health
The best in-shower body lotions for when you’re in a rush
37m ago
Health
Pope Leo begins a 12-day, 3-country South America tour after his cancer surgery
58m ago
Health
Health intel-sharing group warns industry in wake of cyberattack on French blood bank
1h ago
Health
3 charged in $129 million AI scheme targeting thousands of companies
1h ago
